Qsam Biosciences Probability of Future OTC Stock Price Finishing Over 4.49
| QSAMDelisted Stock | USD 4.49 0.05 1.13% |
Qsam |
Qsam Biosciences Target Price Odds to finish over 4.49
The tendency of Qsam OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.49 | 90 days | 4.49 | about 79.28 |
Based on a normal probability distribution, the odds of Qsam Biosciences to move above the current price in 90 days from now is about 79.28 (This Qsam Biosciences probability density function shows the probability of Qsam OTC Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Qsam Biosciences has a beta of 0.11 indicating as returns on the market go up, Qsam Biosciences average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Qsam Biosciences will be expected to be much smaller as well. Additionally Qsam Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Qsam Biosciences Price Density |
| Price |
Predictive Modules for Qsam Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Qsam Biosciences. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Qsam Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Qsam Biosciences is not an exception. The market had few large corrections towards the Qsam Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Qsam Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Qsam Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.03 | |
β | Beta against Dow Jones | 0.11 | |
σ | Overall volatility | 0.49 | |
Ir | Information ratio | -0.03 |
Qsam Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Qsam Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Qsam Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Qsam Biosciences is not yet fully synchronised with the market data | |
| Qsam Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Qsam Biosciences currently holds 7.5 K in liabilities with Debt to Equity (D/E) ratio of 2.08, implying the company greatly relies on financing operations through barrowing. Qsam Biosciences has a current ratio of 0.23, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Qsam Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Qsam Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Qsam Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Qsam to invest in growth at high rates of return. When we think about Qsam Biosciences' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (4.39 M) with profit before overhead, payroll, taxes, and interest of 916.67 K. | |
| Qsam Biosciences currently holds about 429.35 K in cash with (2.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25. | |
| Roughly 52.0% of Qsam Biosciences outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating ... |
Qsam Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Qsam OTC Stock often depends not only on the future outlook of the current and potential Qsam Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Qsam Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3 M | |
| Dividends Paid | 28 B | |
| Cash And Short Term Investments | 1.4 M | |
| Shares Float | 2.1 M |
Qsam Biosciences Technical Analysis
Qsam Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Qsam OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Qsam Biosciences. In general, you should focus on analyzing Qsam OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Qsam Biosciences Predictive Forecast Models
Qsam Biosciences' time-series forecasting models is one of many Qsam Biosciences' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Qsam Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Qsam Biosciences
Checking the ongoing alerts about Qsam Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Qsam Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Qsam Biosciences is not yet fully synchronised with the market data | |
| Qsam Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Qsam Biosciences currently holds 7.5 K in liabilities with Debt to Equity (D/E) ratio of 2.08, implying the company greatly relies on financing operations through barrowing. Qsam Biosciences has a current ratio of 0.23, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Qsam Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Qsam Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Qsam Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Qsam to invest in growth at high rates of return. When we think about Qsam Biosciences' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (4.39 M) with profit before overhead, payroll, taxes, and interest of 916.67 K. | |
| Qsam Biosciences currently holds about 429.35 K in cash with (2.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25. | |
| Roughly 52.0% of Qsam Biosciences outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating ... |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Qsam Biosciences information on this page should be used as a complementary analysis to other Qsam Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Qsam OTC Stock
If you are still planning to invest in Qsam Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qsam Biosciences' history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |